Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial
Clinical trial NCT02508649 · TERMINATED
Trial details
- NCT number
- NCT02508649
- Sponsor
- Ferring Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-10-03
- Enrollment
- 868
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.